PE20000418A1 - Procedimiento para la preparacion de acidos hidroxamicos - Google Patents
Procedimiento para la preparacion de acidos hidroxamicosInfo
- Publication number
- PE20000418A1 PE20000418A1 PE1999000278A PE00027899A PE20000418A1 PE 20000418 A1 PE20000418 A1 PE 20000418A1 PE 1999000278 A PE1999000278 A PE 1999000278A PE 00027899 A PE00027899 A PE 00027899A PE 20000418 A1 PE20000418 A1 PE 20000418A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- reaction
- compound
- hydroxylamine
- base
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 4
- -1 SILYL HALIDE Chemical class 0.000 abstract 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 abstract 3
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 abstract 2
- 150000004820 halides Chemical class 0.000 abstract 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 150000003141 primary amines Chemical class 0.000 abstract 1
- 150000003335 secondary amines Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
QUE COMPRENDE LA REACCION DE HIDROXILAMINA CON HALURO DE SILILO EN PRESENCIA DE UNA BASE, SEGUIDO DE LA REACCION CON UNA MOLECULA QUE CONTIENE UN HALURO DE ACIDO CARBOXILICO SEGUIDO POR LA REACCION CON UN ACIDO, CON LA CONDICION DE QUE LA MOLECULA QUE CONTIENE HALURO DE ACIDO CARBOXILICO NO CONTENGA UN GRUPO HIDROXI, AMINA PRIMARIA, AMINA SECUNDARIA, GRUPO TIOL. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA I, DONDE Z ES >CH2, >NR1; Q ES ALQUILO C1-C6, ARILO C6-C10, (OXIARILO C6-C10)(ALQUILO C1-C6), ENTRE OTROS; R1 ES H, ALQUILO C1-C6, (ARIL C6-C10)(ALQUILO C1-C6), -(CH2)n-C(=O)-OR4, ENTRE OTROS; R2 Y R3 SON H, ALQUILO C1-C6, O FORMAN UN CICLOALQUILO DE 3-7 MIEMBROS, PIRAN-4-ILO, R4 ES ALQUILO C1-C6; n ES 1-6; QUE COMPRENDE LA REACCION DE HIDROXILAMINA CON UN HALURO DE (ALQUIL C1-C6)3SILILO DE PREFERENCIA CLORURO DE TRIMETILSILILO; EN PRESENCIA DE UNA BASE DE PREFERENCIA PIRIDINA, 2,6-LUTIDINA, DIISOPROPILETILAMINA EN UN DISOLVENTE COMO PIRIDINA, FORMANDOSE UNA HIDROXILAMINA (ALQUIL C1-C6)3SILILADA QUE REACCIONA CON UN COMPUESTO II EN PRESENCIA DE UNA BASE, FORMANDOSE UN COMPUESTO DE FORMULA VI; R7 ES (ALQUIL C1-C6)-Si-; R8 ES H, (ALQUIL)3Si-; LUEGO SE HIDROLIZA CON UN ACIDO. EL COMPUESTO I ES UN INHIBIDOR DE METALOPROTEASA DE MATRIZ O DE LA PRODUCCION DEL FACTOR DE NECROSIS TUMORAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8136598P | 1998-04-10 | 1998-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000418A1 true PE20000418A1 (es) | 2000-05-23 |
Family
ID=22163686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000278A PE20000418A1 (es) | 1998-04-10 | 1999-04-06 | Procedimiento para la preparacion de acidos hidroxamicos |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6288246B1 (es) |
| EP (1) | EP0949244A3 (es) |
| JP (1) | JPH11343277A (es) |
| KR (1) | KR100329902B1 (es) |
| CN (1) | CN1232023A (es) |
| AP (1) | AP1203A (es) |
| AR (1) | AR018180A1 (es) |
| AU (1) | AU747629B2 (es) |
| BG (1) | BG64154B1 (es) |
| BR (1) | BR9901089A (es) |
| CA (1) | CA2268680A1 (es) |
| CO (1) | CO5070713A1 (es) |
| DZ (1) | DZ2757A1 (es) |
| EA (1) | EA002777B1 (es) |
| EG (1) | EG22263A (es) |
| GT (1) | GT199900046A (es) |
| HR (1) | HRP990105A2 (es) |
| HU (1) | HUP9901041A3 (es) |
| ID (1) | ID23337A (es) |
| IL (1) | IL129328A0 (es) |
| IN (1) | IN192342B (es) |
| IS (1) | IS5019A (es) |
| MA (1) | MA24831A1 (es) |
| NO (1) | NO991672L (es) |
| NZ (1) | NZ335104A (es) |
| OA (1) | OA11031A (es) |
| PA (1) | PA8469301A1 (es) |
| PE (1) | PE20000418A1 (es) |
| PL (1) | PL332450A1 (es) |
| SG (1) | SG125880A1 (es) |
| SK (1) | SK43699A3 (es) |
| TN (1) | TNSN99052A1 (es) |
| TR (1) | TR199900755A2 (es) |
| TW (1) | TW448147B (es) |
| UA (1) | UA57750C2 (es) |
| UY (1) | UY25460A1 (es) |
| YU (1) | YU18199A (es) |
| ZA (1) | ZA992631B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9918684D0 (en) | 1999-08-09 | 1999-10-13 | Novartis Ag | Organic compounds |
| US6458822B2 (en) | 2000-03-13 | 2002-10-01 | Pfizer Inc. | 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| GB0103303D0 (en) | 2001-02-09 | 2001-03-28 | Novartis Ag | Organic compounds |
| WO2004106319A1 (en) * | 2003-05-30 | 2004-12-09 | Pfizer Products Inc. | Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide |
| AU2003264355A1 (en) * | 2003-08-29 | 2005-03-29 | Basf Aktiengesellschaft | Process for production of o-substituted hydroxylamines |
| EP3082995A4 (en) | 2013-12-18 | 2017-07-05 | Brita LP | Filter assembly for filter as you pour filtration |
| TW202237119A (zh) | 2020-12-10 | 2022-10-01 | 美商住友製藥腫瘤公司 | Ａｌｋ﹘５抑制劑和彼之用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA794723B (en) | 1978-09-11 | 1980-08-27 | Univ Miami | Anti-hypertensive agents |
| GB9000725D0 (en) | 1990-01-12 | 1990-03-14 | Pfizer Ltd | Therapeutic agents |
| US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| EP0922030A1 (en) | 1996-08-23 | 1999-06-16 | Pfizer Inc. | Arylsulfonylamino hydroxamic acid derivatives |
| IL131042A0 (en) | 1997-02-03 | 2001-01-28 | Pfizer Prod Inc | Arylsulfonylamino hydroxamic acid derivatives |
| AU730248B2 (en) | 1997-08-08 | 2001-03-01 | Pfizer Products Inc. | Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| ES2176913T3 (es) | 1997-08-08 | 2002-12-01 | Pfizer Prod Inc | Derivados de acidos arilsulfonilaminohidroxamicos. |
| PA8469401A1 (es) | 1998-04-10 | 2000-05-24 | Pfizer Prod Inc | Derivados biciclicos del acido hidroxamico |
-
1999
- 1999-03-19 PA PA19998469301A patent/PA8469301A1/es unknown
- 1999-03-25 GT GT199900046A patent/GT199900046A/es unknown
- 1999-03-26 EP EP99302343A patent/EP0949244A3/en not_active Withdrawn
- 1999-04-01 OA OA9900074A patent/OA11031A/en unknown
- 1999-04-01 SK SK436-99A patent/SK43699A3/sk unknown
- 1999-04-05 IL IL12932899A patent/IL129328A0/xx unknown
- 1999-04-06 PE PE1999000278A patent/PE20000418A1/es not_active Application Discontinuation
- 1999-04-06 IN IN512DE1999 patent/IN192342B/en unknown
- 1999-04-06 TW TW088105453A patent/TW448147B/zh active
- 1999-04-06 IS IS5019A patent/IS5019A/is unknown
- 1999-04-07 ID IDP990307D patent/ID23337A/id unknown
- 1999-04-07 US US09/287,508 patent/US6288246B1/en not_active Expired - Fee Related
- 1999-04-07 MA MA25526A patent/MA24831A1/fr unknown
- 1999-04-07 DZ DZ990058A patent/DZ2757A1/xx active
- 1999-04-07 TN TNTNSN99052A patent/TNSN99052A1/fr unknown
- 1999-04-07 CN CN99104834A patent/CN1232023A/zh active Pending
- 1999-04-07 UY UY25460A patent/UY25460A1/es not_active Application Discontinuation
- 1999-04-08 SG SG1999001650A patent/SG125880A1/en unknown
- 1999-04-08 EG EG37399A patent/EG22263A/xx active
- 1999-04-08 YU YU18199A patent/YU18199A/sh unknown
- 1999-04-08 TR TR1999/00755A patent/TR199900755A2/xx unknown
- 1999-04-08 UA UA99041999A patent/UA57750C2/uk unknown
- 1999-04-08 KR KR1019990012326A patent/KR100329902B1/ko not_active Expired - Fee Related
- 1999-04-08 AR ARP990101598A patent/AR018180A1/es not_active Application Discontinuation
- 1999-04-08 AP APAP/P/1999/001503A patent/AP1203A/en active
- 1999-04-08 CA CA002268680A patent/CA2268680A1/en not_active Abandoned
- 1999-04-09 JP JP11103156A patent/JPH11343277A/ja active Pending
- 1999-04-09 BR BR9901089-5A patent/BR9901089A/pt not_active IP Right Cessation
- 1999-04-09 ZA ZA9902631A patent/ZA992631B/xx unknown
- 1999-04-09 CO CO99021089A patent/CO5070713A1/es unknown
- 1999-04-09 PL PL99332450A patent/PL332450A1/xx not_active Application Discontinuation
- 1999-04-09 NZ NZ335104A patent/NZ335104A/xx unknown
- 1999-04-09 BG BG103319A patent/BG64154B1/bg unknown
- 1999-04-09 HR HR60/081,365A patent/HRP990105A2/hr not_active Application Discontinuation
- 1999-04-09 NO NO991672A patent/NO991672L/no not_active Application Discontinuation
- 1999-04-09 HU HU9901041A patent/HUP9901041A3/hu unknown
- 1999-04-09 AU AU23690/99A patent/AU747629B2/en not_active Ceased
- 1999-04-09 EA EA199900284A patent/EA002777B1/ru not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK116480A (da) | Fremgangsmaade til fremstilling af substituerede chromoner | |
| BRPI0505310A (pt) | processo para a preparação de soluções aquosas fluxìveis, altamente concentradas, de betaìnas | |
| CO5261501A1 (es) | Derivados de acido pirazol-propionico y sus composiciones farmaceuticas | |
| AR115561A1 (es) | Aditivos para combustible de amonio cuaternario | |
| PE20050631A1 (es) | Compuestos derivados de amina como inhibidores de la reabsorcion de serotonina y de noradrenalina | |
| BR9612099A (pt) | Processo para preparar um composto derivado de piperidina, regioisÈmero, processo para preparar um regioisÈmero, derivado de ácido 4-( alfa,alfa, di-substuìdo) toluico e 4- (alfa, alfa-di-não substitìdo) toluico. | |
| PE20000418A1 (es) | Procedimiento para la preparacion de acidos hidroxamicos | |
| GB1143882A (es) | ||
| ES2046671T3 (es) | Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-tionas. | |
| AR036000A1 (es) | Proceso para la preparacion de derivados de indol y novedosos intermediarios | |
| BR0012771A (pt) | Processo para preparar uma composição de esterquat | |
| BR0314216A (pt) | Processo para a produção de uma composição combustìvel | |
| AR015745A1 (es) | Metodo para producir un compuesto isoxazolidindiona | |
| DE60106048D1 (de) | Matrix metalloproteinase inhibitoren | |
| AR053722A2 (es) | Procedimiento para preparar secretagogos de hormonas del crecimiento y poliformo de los compuestos obtenidos | |
| BR9809473A (pt) | Mistura fungida, e, processo para controlar fungos nocivos | |
| GB807899A (en) | New photographic developers | |
| ES8607922A1 (es) | Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos | |
| GB1316361A (en) | 5h-dibenzazepines | |
| CO5550441A2 (es) | Nuevos derivados de ziprasidona, procedimientos para prepararlos y composiciones que los contienen | |
| ES8403888A1 (es) | Un procedimiento para la preparacion de un 1h- o 2h-tetrazol-5-tiol. | |
| BR0006978A (pt) | Processo para preparação de 1,5-diaril-3-pirazóis substituìdos | |
| ES8403891A1 (es) | Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico | |
| GB673413A (en) | New local anaesthetics which are substituted benzoic esters and processes for making the same | |
| GB847205A (en) | A process for the manufacture of ethylenimine derivatives and novel ethylenimine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |